Texas Children’s Hospital and Baylor College of Medicine –
Dr. Michael Taylor – Building a Roadmap to Find Early Group 3 Medulloblastoma – The project will compliment the Group 3 single cell dataset with spatial sequencing, to see how the various cell types relate to each other, and how they signal to each other to maintain the tumor, and presumably the ‘cerebellar polyp’ as well.
ASCO/Conquer cancer –Team Science Grant in Medulloblastoma powered by EveryGrant® to a group of researchers at Sidney Kimmel Cancer Center/Johns Hopkins Medicine who will study a new approach for reducing the risk of cerebellar mutism syndrome (CMS) and neurocognitive outcome following CMS in pediatric patients with medulloblastoma.
Children’s Brain Tumor Network (CBTN) Precision Medicine
project comprises two interrelated efforts supporting the advancement of recurrent medulloblastoma precision medicine.
A Targeted Approach to Medulloblastoma Treatment
Cell-free DNA identifies early signs of relapse in pediatric medulloblastoma
ASCO Young Investigators Award: Cerebrospinal fluid derived circulating tumor DNA as an actionable biomarker in
medulloblastoma, Dr Anthony Lui
